NDC 51655-065

Benazepril HCl

Benazepril Hcl

Benazepril HCl is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is Benazepril Hydrochloride.

• Product ID: 51655-065_3631d1dc-45e2-0588-e054-00144ff88e88
• NDC: 51655-065
• Product Type: Human Prescription Drug
• Proprietary Name: Benazepril HCl
• Generic Name: Benazepril Hcl
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2016-06-23
• Marketing Category: ANDA / ANDA
• Application Number: ANDA076118
• Labeler Name: Northwind Pharmaceuticals
• Substance Name: BENAZEPRIL HYDROCHLORIDE
• Active Ingredient Strength: 10 mg/1
• Pharm Classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51655-065-52

30 TABLET in 1 BOTTLE (51655-065-52)

• Marketing Start Date: 2016-06-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51655-065-52 [51655006552]

Benazepril HCl TABLET

• Marketing Category: ANDA
• Application Number: ANDA076118
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-06-23
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
BENAZEPRIL HYDROCHLORIDE	10 mg/1

OpenFDA Data

• SPL SET ID: 3631d1dc-45e1-0588-e054-00144ff88e88
• Manufacturer:
  • Northwind Pharmaceuticals
• UNII:
  • N1SN99T69T
• RxNorm Concept Unique ID - RxCUI:
  • 898687

Pharmacological Class

• Angiotensin Converting Enzyme Inhibitor [EPC]
• Angiotensin-converting Enzyme Inhibitors [MoA]
• Decreased Blood Pressure [PE]